Can a Death Doula Support Someone with Advanced Pancreatic Neuroendocrine Tumor (pNET)?
By CRYSTAL BAI •
The short answer: Yes. A death doula can support someone with advanced pancreatic neuroendocrine tumor (pNET) by navigating a cancer with better prognosis than pancreatic adenocarcinoma but still life-limiting in metastatic stages, supporting through the unique symptom burdens of hormonal syndromes, and providing compassionate presence as treatment options narrow.
Can a Death Doula Support Someone with Advanced Pancreatic Neuroendocrine Tumor (pNET)?
Pancreatic neuroendocrine tumors (pNETs) are distinct from pancreatic adenocarcinoma in that they are generally slower-growing and more treatable. Many patients live for years or decades with metastatic pNET. But high-grade or treatment-refractory pNET can become life-limiting, and even lower-grade disease ultimately leads to end-of-life considerations. A death doula provides essential support through this journey.
pNET Disease Trajectory
Low-grade pNETs (Grade 1-2) can be monitored with watchful waiting or treated with somatostatin analogs (octreotide, lanreotide), everolimus, sunitinib, or PRRT (peptide receptor radionuclide therapy). High-grade pNETs (Grade 3) are more aggressive and may require cytotoxic chemotherapy. A death doula helps patients and families navigate the treatment landscape and think ahead.
Hormonal Syndromes in pNET
Some pNETs are functional — secreting hormones that cause distinct symptoms. Insulinomas cause hypoglycemia; gastrinomas cause severe ulcer disease (Zollinger-Ellison syndrome); VIPomas cause watery diarrhea. Managing these symptoms is central to quality of life in pNET. A death doula helps patients and families understand and advocate for management of these complex presentations.
How Renidy Supports pNET Families
Renidy connects pNET patients and families with death doulas experienced in neuroendocrine tumors, who can provide support through the treatment journey and ultimately through end-of-life care.
Frequently Asked Questions
Is pNET the same as pancreatic cancer?
No. Pancreatic neuroendocrine tumors are distinct from pancreatic adenocarcinoma — the more common and aggressive 'pancreatic cancer.' pNETs arise from endocrine cells in the pancreas and generally have a better prognosis, with many patients living years even with metastatic disease. However, high-grade pNETs are more aggressive.
What is PRRT and is it used for pNET?
Peptide receptor radionuclide therapy (PRRT) using Lu-177 DOTATATE (Lutathera) is a targeted radioligand therapy approved for somatostatin receptor-positive gastroenteropancreatic NETs, including pNETs. It can provide meaningful disease control and symptom relief in advanced disease.
When should pNET patients consider palliative care?
Palliative care is appropriate for pNET patients at any stage with significant symptom burden (from hormonal syndromes, tumor burden, or treatment side effects), advanced high-grade disease, or when transitioning from active treatment to symptom management. Early integration improves quality of life.
Are there support resources for pNET patients?
The Neuroendocrine Tumor Research Foundation (netrf.org), Carcinoid Cancer Foundation, and North American Neuroendocrine Tumor Society (NANETS) provide patient resources. Renidy's death doulas provide complementary one-on-one support for patients and families.
Renidy connects grieving families with compassionate death doulas and AI-powered funeral planning tools. Try our free AI funeral planner or find a death doula near you.